Cordatus Wealth Management LLC Regeneron Pharmaceuticals, Inc. Transaction History

Cordatus Wealth Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 02, 2021	SELL	$478.3 - $607.98 $499,345 - $634,731	-1,044 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$544.75 - $658.21 $1,089 - $1,316	2 Added 0.19%	1,044 $584,000
Q2 2020 Jul 21, 2020	SELL	$493.32 - $643.92 $474,080 - $618,807	-961 Reduced 47.98%	1,042 $650,000
Q1 2020 Apr 21, 2020	BUY	$336.18 - $494.43 $673,368 - $990,343	2,003 New	2,003 $978,000
Q2 2019 Jul 29, 2019	SELL	$299.6 - $414.82 $3.1 Million - $4.29 Million	-10,350 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$372.08 - $439.57 $3.85 Million - $4.55 Million	10,350 New	10,350 $4.25 Million

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Cordatus Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Cordatus Wealth Management LLC with notifications on news.